Anthropic’s Biggest Claude Moves

🤩 KAIST’s researchers revolutionize cancer drug design, Create cinematic product videos in minutes with Seedance Pro, and more!

Hola Decoder😎

If someone forwarded this to you and you want to Decode the power of AI and be limitless, then subscribe now and Join Decode alongside 30k+ code-breakers untangling AI.

🚀 Anthropic Expands Claude’s Capabilities with 1M Context, $1 Gov Access, and Chat Memory

Anthropic just rolled out its biggest upgrades yet for Claude, from record-breaking context windows to government expansion and smarter chat continuity. The move positions Claude to compete harder with GPT-5, win developer loyalty, and deepen its public sector footprint.

The Decode:

1. 1M Token Context for Claude Sonnet 4 - Enterprise/API users can now feed Claude Sonnet 4 up to 1M tokens, that’s 750,000 words or 75,000 lines of code, over 5× its previous limit. Available via API, AWS Bedrock, and Google Vertex AI, with tiered pricing for prompts over 200k tokens.

2. Strategic Public Sector Play - In a direct challenge to OpenAI, Anthropic is offering Claude to all three branches of the U.S. government for $1/year for one year. The package includes Claude for Government with FedRAMP High certification, supporting sensitive unclassified workloads and multi-cloud deployment via AWS, Google Cloud, and Palantir. 

3. Chat Continuity for Enterprise Plans -  A new memory feature lets Claude recall and reference past conversations, making it easier to resume projects without re-prompting. Rolling out now to Max, Team, and Enterprise tiers, with broader availability on the way.

Anthropic is stacking capability, price strategy, and platform usability to lock in enterprise and government clients while fending off GPT-5. For developers, coders, and public sector teams, these updates mean more context, more control, and less friction in using AI at scale.

Together with Shipfusion

😰 Is Your Fulfillment Experience Chasing Customers Away?

Most DTC brands don't realize where they're losing repeat customers: after the sale.

To find out what great post-purchase CX actually looks like, Shipfusion placed orders with 30+ deodorant brands and dissected the entire experience.

The result? A detailed playbook for optimizing your fulfillment, CX, and retention strategy.

Inside, you'll learn:

👉 How referral inserts can boost customer acquisition by up to 20%
👉 How surprise freebies can raise repeat purchase likelihood by 27%
👉 How branded tracking pages keep customers engaged until delivery

It’s not just about deodorant. It’s about fixing the invisible friction that’s hurting LTV across every DTC category. Whether you're selling skincare, supplements, or pet care, this is the audit you can’t skip.

Download the report and turn post-purchase into your most profitable channel.

🤩Create Pro-Grade Product Videos with Seedance Pro in Higgsfield

  1. Open Create → Video – Sign in at higgsfield.ai and select Seedance Pro as your model.
  2. Choose Motion – Pick a camera move (push-in, orbit, dolly, etc.) that fits your product story.
  3. Upload Image – Add a clean product shot (PNG/JPG).
  4. Write Prompt & Generate – Describe scene, lighting, background, and vibe. Click Generate, tweak motion or prompt if needed.
  5. Add More Shots – Repeat with new angles and motions for variety.
  6. Assemble & Export – Combine clips in Canvas, add text/logo, export in desired format.

Conclusion: With Seedance Pro, you can go from static image to multi-shot cinematic product video in minutes, perfect for ads, launches, or social content without a film crew.

Together with GetResponse

You Built the Audience, Now It’s Time to Actually Own It

You might have a big following on Instagram. You might be crushing it on TikTok - until the platform changes the rules.

Your account gets shadowbanned. Your traffic drops. You have no idea why.

Because the truth is: your audience isn’t yours. It’s theirs.

This free ebook from GetResponse shows you how to shift from platform dependency to ownership and start owning what matters.

It’s a tactical, no-fluff playbook for turning reach into revenue using assets you control.

Here’s what you’ll get inside:

✅ A 3-step funnel strategy for converting attention into email subscribers
🧠 Automation blueprints to nurture leads without lifting a finger
📉 Real examples of brands that scaled after shifting off social
📋 A self-audit checklist to spot the weak links in your current setup

Whether you’re just starting out or scaling fast, it isn’t about abandoning social (that'd be unreasonable), but about diversifying your marketing channels and starting to own your customer data. 

Download the free ebook and start owning your audience today!

🧪 KAIST’s BInD: AI That Designs Cancer Drugs from Scratch

KAIST researchers have unveiled BInD, an AI model that can design optimal cancer drug candidates from only the target protein’s structure, no prior molecular data required. It combines drug creation and binding mechanism prediction into a single step, streamlining discovery.

The Decode:

1. One-step design for targeted drugs - BInD generates the drug molecule and predicts how it will bind to diseased proteins simultaneously, eliminating the traditional trial-and-error cycles of designing and testing separately. 

2. Precision and safety built in - The AI designs molecules that selectively bind to cancer-causing mutations while sparing healthy protein versions, optimizing for multiple factors, binding affinity, drug-like properties, and stability, at once, avoiding trade-offs common in older systems.

3. Learns and improves with “recycling” - BInD reuses successful binding patterns from prior results, improving new drug candidates without retraining. It’s grounded in chemical laws like bond lengths and protein-ligand distances for realistic structure generation. The model successfully targeted mutated EGFR proteins linked to cancer.

Drug discovery is slow, risky, and expensive, but BInD’s generative, one-step process could slash timelines and open the door to tailored, effective cancer treatments. With AI-designed drugs already emerging, tools like BInD could accelerate a wave of transformative medicines.

🏆 Tools you Cannot Miss:

📱 TheLibrarian.io – Supercharge your day with a WhatsApp AI Assistant. Get instant answers, reminders, and task automation directly in chat.

✍️ Outwrite – Create content AI systems cite 10x more. Designed for writers, researchers, and marketers who need high-authority output.

🛍️ Etshop – Discover best-selling products on Etsy. Perfect for eCommerce sellers seeking trending ideas and competitive insights.

🧪 TestDriver – The first QA AI agent for engineering teams. Runs automated tests, catches bugs early, and speeds up releases.

📚 15Minutes – Get any book's essence in 15 minutes. Save time with concise, actionable summaries you can read or listen to.

🚀 Quick Hits

💼 Perplexity made a $34.5B bid for Google’s Chrome, pledging open-source investment and keeping Google search, amid DOJ antitrust pressure, despite its valuation and funding being far below the offer.

👨‍💻 The Trump administration says its 15% revenue-sharing deal for AI chip exports to China is still under legal review by the Department of Commerce, and could later extend to other companies.

🤖 OpenAI restored ChatGPT’s model picker with Auto, Fast, and Thinking modes for GPT-5, re-enabled legacy models, and plans personality updates after router issues and user backlash over model deprecations.

🧠 Mistral launched Medium 3.1, an upgraded model with stronger performance and enhanced creative writing, offering improved narrative quality, style versatility, and overall capability for a range of applications.

⚖️  Elon Musk says xAI will sue Apple, alleging its App Store rankings unfairly favor OpenAI’s ChatGPT over his apps, X and Grok. Apple denies bias, citing objective curation criteria. OpenAI CEO Sam Altman countered by pointing to past claims that Musk boosted his own posts on X.

Thanks for Decoding with us🥳

Your feedback is the key to our code! Help us elevate your Decode experience by hitting reply and sharing your input on our content and style.

Keep deciphering the AI enigma, and we'll be back with more coded mysteries unraveled just for you!